FDA Drug Application (200961) for NORETHINDRONE by NOVAST LABS

Back to FDA Applications sponsored by NOVAST LABS

Application Number200961
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNORETHINDRONE
Active IngredientNORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by NOVAST LABS